| Resources |
|
| Government |
| Quick access to information based on government's structure
|
|
 |
|
|
Limited Coverage Drugs - Special Authority Criteria
| Generic Name / Strength / Form |
| lacosamide 50mg, 100mg, 150mg, 200mg tablet |
| Criteria |
Approval Period |
As last resort adjunctive therapy (used in combination with at least ONE other anti‑epileptic drug) for partial-onset seizures in adults AFTER documented ineffectiveness/intolerance OR contraindications to other available anti-epileptic drugs (see Special Notes below) |
Indefinite |
Practitioner Exemptions
- No practitioner exemptions
Special Notes
- Special Authority requests should include documentation of which other anti-epileptic drugs have been trialed in adequate doses. Examples of other anti-epileptic drugs include: phenytoin (Dilantin®), carbamazepine (Tegretol®), gabapentin (Neurontin®), topiramate (Topamax®), lamotrigine (Lamictal®), levetiracetam (Keppra®), vigabatrin (Sabril®) and valproic acid (Epival®).
Special Authority Request Forms
Online Forms (PDF)
Click on the link to complete a special authority request form.
|
|
|